Health Care Resource Utilization Following Acute Myocardial Infarction: Findings from the RECORD-MI Registry.

Autor: Talha KM; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi., Hammonds K; Baylor Scott & White Research Institute, Dallas, Texas., Alhamdow A; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Bennett MM; Baylor Scott & White Research Institute, Dallas, Texas., Bomar JVA; Baylor Scott & White Research Institute, Dallas, Texas., Ettlinger JA; Baylor Scott & White Research Institute, Dallas, Texas., Martinez-Traba M; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Hartgers-Gubbels ES; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Priest EL; Baylor Scott & White Research Institute, Dallas, Texas., Shaver CN; Baylor Scott & White Research Institute, Dallas, Texas., Afzal A; Heart Recovery Center, Baylor Scott and White The Heart Hospital Plano, Plano, Texas., Widmer RJ; Department of Cardiology, Baylor Scott & White Medical Center - Temple, Temple, Texas., Gottlieb RL; Baylor Scott & White Research Institute, Dallas, Texas; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas; Department of Medicine, Texas A&M Health Science Center, Dallas, Texas; Department of Medicine, Burnett School of Medicine, Texas Christian University, Fort Worth, Texas; Baylor Scott & White The Heart Hospital Plano, Plano, Texas., Mack MJ; Baylor Scott & White Research Institute, Dallas, Texas; Baylor Scott & White The Heart Hospital Plano, Plano, Texas., Butler J; Baylor Scott & White Research Institute, Dallas, Texas; Department of Medicine, University of Mississippi, Jackson, Mississippi. Electronic address: javed.bulter@bswhealth.org.
Jazyk: angličtina
Zdroj: The American journal of cardiology [Am J Cardiol] 2024 Dec 01; Vol. 232, pp. 1-7. Date of Electronic Publication: 2024 Sep 07.
DOI: 10.1016/j.amjcard.2024.08.034
Abstrakt: The contemporary health care resource utilization after an acute myocardial infarction (MI) is not well-known. All patients admitted because of MI between January 2015 and December 2021 across 28 hospitals in the Baylor Scott & White Health system were studied. Patient characteristics and outcomes, including all-cause and cardiovascular (CV) rehospitalizations, emergency department (ED) visits, and outpatient visits were evaluated. Of 6,804 patients admitted because of MI, 6,556 were discharged alive. The median age was 69 years, 60% were men, and 77% had non-ST-elevation MI; 17% (1,090) had multivessel disease. The number of patients with first all-cause readmissions within 30 days, 3 months, and 12 months of discharge were 844 (13%), 1,372 (21%), and 2,306 (35%), respectively, with a higher readmission rate in patients with non-ST-elevation MI, previous heart failure (HF), new-onset HF, and left ventricular ejection fraction ≤40%. ED visits at 12 months for any cause were 2,401 (37%), of which 1,321 (55%) were for any CV cause, with a higher incidence in patients with previous HF. Of the 6,556 patients, 4,102 (63%) had at least 1 primary care visit in the past year, 5,009 (76%) had CV specialty visits, and 3,860 (59%) had non-CV visits, with a similar distribution across subgroups. Patients hospitalized with an MI had a high risk of subsequent hospital readmissions and ED and outpatient visits, especially those with a previous HF diagnosis and those discharged with an MI and HF diagnosis.
Competing Interests: Declaration of competing interest Dr. Butler reports financial support was provided by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance. Dr. Afzal reports a relationship with AstraZeneca that includes: speaking and lecture fees. Dr. Alhamdow reports a relationship with Boehringer Ingelheim GmbH that includes: employment. Dr. Hartgers-Gubbels reports a relationship with Boehringer Ingelheim GmbH that includes: employment. Dr. Martinez-Traba reports a relationship with Boehringer Ingelheim GmbH that includes: employment. Dr. Butler reports a relationship with Abbott that includes: consulting or advisory. Dr. Butler reports a relationship with American Regent Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Amgen Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Applied Therapeutics Inc that includes: consulting or advisory. Dr. Butler reports a relationship with AskBio that includes: consulting or advisory. Dr. Butler reports a relationship with Astellas that includes: consulting or advisory. Dr. Butler reports a relationship with AstraZeneca that includes: consulting or advisory and speaking and lecture fees. Dr. Butler reports a relationship with Bayer that includes: consulting or advisory. Dr. Butler reports a relationship with Boehringer Ingelheim that includes: consulting or advisory and speaking and lecture fees. Dr. Butler reports a relationship with Boston Scientific Corporation that includes: consulting or advisory. Dr. Butler reports a relationship with Bristol Myers Squibb Co that includes: consulting or advisory. Dr. Butler reports a relationship with Cardiac Dimensions Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Cardiocell that includes: consulting or advisory. Dr. Butler reports a relationship with Cardior that includes: consulting or advisory. Dr. Butler reports a relationship with Cardiorem that includes: consulting or advisory. Dr. Butler reports a relationship with CSL Behring that includes: consulting or advisory. Dr. Butler reports a relationship with CVRx Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Cytokinetics Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Edwards Lifesciences Corporation that includes: consulting or advisory. Dr. Butler reports a relationship with Daxor that includes: consulting or advisory. Dr. Butler reports a relationship with Element Science that includes: consulting or advisory. Dr. Butler reports a relationship with Faraday that includes: consulting or advisory. Dr. Butler reports a relationship with Foundry that includes: consulting or advisory. Dr. Butler reports a relationship with G3P that includes: consulting or advisory. Dr. Butler reports a relationship with Innolife that includes: consulting or advisory. Dr. Butler reports a relationship with Impulse Dynamics that includes: consulting or advisory and speaking and lecture fees. Dr. Butler reports a relationship with Imbria that includes: consulting or advisory. Dr. Butler reports a relationship with Inventiva that includes: consulting or advisory. Dr. Butler reports a relationship with Ionis that includes: consulting or advisory. Dr. Butler reports a relationship with Lexicon that includes: consulting or advisory. Dr. Butler reports a relationship with Eli Lilly and Company that includes: consulting or advisory and speaking and lecture fees. Dr. Butler reports a relationship with LivaNova that includes: consulting or advisory. Dr. Butler reports a relationship with Janssen that includes: consulting or advisory. Dr. Butler reports a relationship with Medtronics that includes: consulting or advisory. Dr. Butler reports a relationship with Merck & Co Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Occlutech that includes: consulting or advisory. Dr. Butler reports a relationship with Owkin Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Novartis that includes: consulting or advisory and speaking and lecture fees. Dr. Butler reports a relationship with Novo Nordisk Inc that includes: consulting or advisory. Dr. Butler reports a relationship with Pfizer that includes: consulting or advisory. Dr. Butler reports a relationship with Pharmacosmos that includes: consulting or advisory. Dr. Butler reports a relationship with PharmaIN that includes: consulting or advisory. Dr. Butler reports a relationship with Prolaio that includes: consulting or advisory. Dr. Butler reports a relationship with Regeneron that includes: consulting or advisory. Dr. Butler reports a relationship with Renibus Therapeutics, Inc. that includes: consulting or advisory. Dr. Butler reports a relationship with Roche that includes: consulting or advisory. Dr. Butler reports a relationship with Salamandra that includes: consulting or advisory. Dr. Butler reports a relationship with Sanofi that includes: consulting or advisory. Dr. Butler reports a relationship with SC Pharma that includes: consulting or advisory. Dr. Butler reports a relationship with Secretome that includes: consulting or advisory. Dr. Butler reports a relationship with Sequana that includes: consulting or advisory. Dr. Butler reports a relationship with SQ Innovation that includes: consulting or advisory. Dr. Butler reports a relationship with Tenex that includes: consulting or advisory. Dr. Butler reports a relationship with Tricog that includes: consulting or advisory. Dr. Butler reports a relationship with Ultromics that includes: consulting or advisory. Dr. Butler reports a relationship with Vifor that includes: consulting or advisory. Dr. Butler reports a relationship with ZOLL that includes: consulting or advisory. Dr. Gottlieb reports a relationship with Alnylam Pharmaceuticals Inc that includes: consulting or advisory, funding grants, and speaking and lecture fees. Dr. Gottlieb reports a relationship with AstraZeneca that includes: consulting or advisory and funding grants. Dr. Gottlieb reports a relationship with Eli Lilly and Company that includes: consulting or advisory and funding grants. Dr. Gottlieb reports a relationship with Pfizer that includes: funding grants and speaking and lecture fees. Dr. Gottlieb reports a relationship with Johnson & Johnson that includes: funding grants. Dr. Priest reports a relationship with AstraZeneca that includes: funding grants. Dr. Priest reports a relationship with Owkin Inc that includes: funding grants. The remaining authors have no competing interests to declare.
(Copyright © 2024. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: